Paxlovid May Cut Your Risk Of Long COVID, New Study Shows

and scientists have been eager to develop long COVID treatment options that can effectively prevent and treat the condition that has been“It’s very exciting, because it suggests that there is a way to decrease the incidence of long COVID, and obviously that’s become one of the scariest aspects of COVID,” Dr., the director of the Institute of Molecular Medicine at the Feinstein Institutes for Medical Research, told HuffPost.

For the study, the researchers evaluated medical records sourced from the U.S. Department of Veterans Affairs of 56,340 patients who had tested positive for COVID-19 between March and June 2022 and had at least one risk factor for severe COVID-19. Of the group, 9,217 patients were treated with Paxlovid within five days of being diagnosed and 47,123 did not receive the medication. The research team then calculated how effective the treatment was up to 90 days after the infection and found that those who took Paxlovid — three pills taken twice a day for five days — had a 26% lower risk of long COVID.Paxlovid was associated with a lower risk for a range of long-COVID symptoms.

The new findings suggest that Paxlovid can significantly lower the risk of long COVID among people who are at risk of severe diseases, and the researchers hope the report will encourage more doctors to prescribe the pills to eligible patients. “At the time you get COVID, this can diminish your likelihood of getting long COVID,” Diamond said.

Source: Healthcare Press (healthcarepress.net)

And increase your risk of a deadly bloodclot

After they recovered from the fatigue from massive diarrhea maybe.

abusulayman 💐🇸🇦✍️

I stuck one up my bum, was healthy the next day

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New VA study finds Paxlovid may cut the risk of long COVIDFor those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID. More drug pushing. Really annoying when you don’t provide a link to the study in a story about a study *article sponsored by Pfizer
Source: NPRHealth - 🏆 144. / 63 Read more »

New VA study finds Paxlovid may cut the risk of long COVIDFor those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID.
Source: WBUR - 🏆 274. / 63 Read more »

New VA study finds Paxlovid may cut the risk of long COVIDFor those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID.
Source: KPBSnews - 🏆 240. / 63 Read more »

Study shows Paxlovid may help prevent long COVIDAs many as 4 million people are suffering from brain fog, headaches, chest pain, and other long COVID symptoms. Paxlovid could help prevent them.
Source: PopSci - 🏆 298. / 63 Read more »

Paxlovid may reduce long covid risk for some patients, VA study findsThe report showed an approximately 25 percent reduction in 10 of the 12 symptoms studied, including the common complaints of lingering fatigue and brain fog.
Source: washingtonpost - 🏆 95. / 72 Read more »